{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T09:10:00Z","timestamp":1791882600108,"version":"4.3.4"},"reference-count":81,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,1,13]],"date-time":"2022-01-13T00:00:00Z","timestamp":1642032000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,1,13]],"date-time":"2022-01-13T00:00:00Z","timestamp":1642032000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The novel coronavirus disease (COVID-19) is currently a big concern around the world. Recent reports show that the disease severity and mortality of COVID-19 infected patients may vary from gender to gender with a very high risk of death for seniors. In addition, some steroid structures have been reported to affect coronavirus, SARS-CoV-2, function and activity. The entry of SARS-CoV-2 into host cells depends on the binding of coronavirus spike protein to angiotensin converting enzyme-2 (ACE2). Viral main protease is essential for the replication of SARS-CoV-2. It was hypothesized that steroid molecules (e.g., estradiol, progesterone, testosterone, dexamethasone, hydrocortisone, prednisone and calcitriol) could occupy the active site of the protease and could alter the interaction of spike protein with ACE2. Computational data showed that estradiol interacted more strongly with the main protease active site. In the presence of calcitriol, the binding energy of the spike protein to ACE2 was increased, and transferring Apo to Locked S conformer of spike trimer was facilitated. Together, the interaction between spike protein and ACE2 can be disrupted by calcitriol. Potential use of estradiol and calcitriol to reduce virus invasion and replication needs clinical investigation.<\/jats:p>","DOI":"10.1038\/s41598-022-04778-y","type":"journal-article","created":{"date-parts":[[2022,1,13]],"date-time":"2022-01-13T11:03:33Z","timestamp":1642071813000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["The impact of calcitriol and estradiol on the SARS-CoV-2 biological activity: a molecular modeling approach"],"prefix":"10.1038","volume":"12","author":[{"given":"Alireza","family":"Mansouri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rasoul","family":"Kowsar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mostafa","family":"Zakariazadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hassan","family":"Hakimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akio","family":"Miyamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,1,13]]},"reference":[{"key":"4778_CR1","first-page":"339","volume":"34","author":"P Conti","year":"2020","unstructured":"Conti, P. & Younes, A. Coronavirus COV-19\/SARS-CoV-2 affects women less than men: Clinical response to viral infection. J. Biol. Regul. Homeost. Agents 34, 339\u2013343 (2020).","journal-title":"J. Biol. Regul. Homeost. Agents"},{"key":"4778_CR2","doi-asserted-by":"crossref","first-page":"152","DOI":"10.3389\/fpubh.2020.00152","volume":"8","author":"JM Jin","year":"2020","unstructured":"Jin, J. M. et al. Gender differences in patients with COVID-19: focus on severity and mortality. Front. Public Health 8, 152 (2020).","journal-title":"Front. Public Health"},{"key":"4778_CR3","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1016\/j.jaccas.2020.04.027","volume":"2","author":"G Sharma","year":"2020","unstructured":"Sharma, G., Volgman, A. S. & Michos, E. D. Sex differences in mortality from COVID-19 pandemic: Are men vulnerable and women protected?. JACC Case Rep. 2, 1407\u20131410 (2020).","journal-title":"JACC Case Rep."},{"key":"4778_CR4","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1017\/ice.2020.64","volume":"41","author":"S Zhao","year":"2020","unstructured":"Zhao, S. et al. COVID-19 and gender-specific difference: Analysis of public surveillance data in Hong Kong and Shenzhen, China, from January 10 to February 15, 2020. Infect. Control Hosp. Epidemiol. 41, 750\u2013751 (2020).","journal-title":"Infect. Control Hosp. Epidemiol."},{"key":"4778_CR5","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.ijwd.2020.04.011","volume":"6","author":"DF Murrell","year":"2020","unstructured":"Murrell, D. F. & Murase, J. E. The dermatologist\u2019s perspective: Why is COVID-19 mortality lower in females than males?. Int. J. Womens Dermatol. 6, 152\u2013153 (2020).","journal-title":"Int. J. Womens Dermatol."},{"key":"4778_CR6","doi-asserted-by":"crossref","first-page":"e1008520","DOI":"10.1371\/journal.ppat.1008520","volume":"16","author":"Y Meng","year":"2020","unstructured":"Meng, Y. et al. Sex-specific clinical characteristics and prognosis of coronavirus disease-19 infection in Wuhan, China: A retrospective study of 168 severe patients. PLoS Pathog. 16, e1008520 (2020).","journal-title":"PLoS Pathog."},{"key":"4778_CR7","doi-asserted-by":"crossref","first-page":"190","DOI":"10.3389\/fmed.2020.00190","volume":"7","author":"H Li","year":"2020","unstructured":"Li, H. et al. Age-dependent risks of incidence and mortality of COVID-19 in Hubei Province and other parts of China. Front. Med. 7, 190 (2020).","journal-title":"Front. Med."},{"key":"4778_CR8","doi-asserted-by":"crossref","first-page":"111255","DOI":"10.1016\/j.mad.2020.111255","volume":"188","author":"C Leung","year":"2020","unstructured":"Leung, C. Risk factors for predicting mortality in elderly patients with COVID-19: A review of clinical data in China. Mech. Ageing Dev. 188, 111255 (2020).","journal-title":"Mech. Ageing Dev."},{"key":"4778_CR9","doi-asserted-by":"crossref","unstructured":"Liu, Y. et al. Association between age and clinical characteristics and outcomes of COVID-19. Eur. Respir. J. 55 (2020).","DOI":"10.1183\/13993003.01112-2020"},{"issue":"11","key":"4778_CR10","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1089\/15409990260363661","volume":"2002","author":"MA Freedman","year":"2002","unstructured":"Freedman, M. A. Quality of life and menopause: The role of estrogen. J. Womens Health 2002(11), 703\u2013718 (2002).","journal-title":"J. Womens Health"},{"key":"4778_CR11","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1007\/s00404-018-4650-7","volume":"297","author":"B Bodner-Adler","year":"2018","unstructured":"Bodner-Adler, B. et al. Association of endogenous circulating sex steroids and condition-specific quality of life domains in postmenopausal women with pelvic floor disorders. Arch. Gynecol. Obstet. 297, 725\u2013730 (2018).","journal-title":"Arch. Gynecol. Obstet."},{"key":"4778_CR12","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1002\/mrd.22355","volume":"81","author":"R Kowsar","year":"2014","unstructured":"Kowsar, R. et al. Evidence for a novel, local acute-phase response in the bovine oviduct: Progesterone and lipopolysaccharide up-regulate alpha 1-acid-glycoprotein expression in epithelial cells in vitro. Mol. Reprod. Dev. 81, 861\u2013870 (2014).","journal-title":"Mol. Reprod. Dev."},{"key":"4778_CR13","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1210\/js.2018-00186","volume":"3","author":"VE Bianchi","year":"2019","unstructured":"Bianchi, V. E. The anti-inflammatory effects of testosterone. J. Endocr. Soc. 3, 91\u2013107 (2019).","journal-title":"J. Endocr. Soc."},{"key":"4778_CR14","doi-asserted-by":"crossref","first-page":"622","DOI":"10.4103\/0253-7613.144922","volume":"46","author":"AN Aksoy","year":"2014","unstructured":"Aksoy, A. N. et al. The effect of progesterone on systemic inflammation and oxidative stress in the rat model of sepsis. Indian J. Pharmacol. 46, 622\u2013626 (2014).","journal-title":"Indian J. Pharmacol."},{"key":"4778_CR15","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1084\/jem.20060336","volume":"203","author":"SM Abraham","year":"2006","unstructured":"Abraham, S. M. et al. Antiinflammatory effects of dexamethasone are partly dependent on induction of dual specificity phosphatase 1. J. Exp. Med. 203, 1883\u20131889 (2006).","journal-title":"J. Exp. Med."},{"key":"4778_CR16","first-page":"1","volume":"4","author":"A Musba","year":"2015","unstructured":"Musba, A., Tanra, H., Yusuf, I. & Ahmad, R. The effect of dexamethasone on the dynamics of inflammation, cortisol and analgesia in lower limb surgery. J. Pain Relief 4, 1\u20136 (2015).","journal-title":"J. Pain Relief"},{"key":"4778_CR17","doi-asserted-by":"crossref","first-page":"E756","DOI":"10.1503\/cmaj.200645","volume":"192","author":"Z Ye","year":"2020","unstructured":"Ye, Z. et al. Efficacy and safety of corticosteroids in COVID-19 based on evidence for COVID-19, other coronavirus infections, influenza, community-acquired pneumonia and acute respiratory distress syndrome: A systematic review and meta-analysis. CMAJ 192, E756\u2013E767 (2020).","journal-title":"CMAJ"},{"key":"4778_CR18","first-page":"m3472","volume":"370","author":"E Mahase","year":"2020","unstructured":"Mahase, E. Covid-19: Hydrocortisone can be used as alternative to dexamethasone, review finds. BMJ (Clin. Res. Ed.) 370, m3472 (2020).","journal-title":"BMJ (Clin. Res. Ed.)"},{"key":"4778_CR19","unstructured":"Corral, L. et al. GLUCOCOVID: A controlled trial of methylprednisolone in adults hospitalized with COVID-19 pneumonia. MedRxiv (2020)."},{"key":"4778_CR20","unstructured":"Jeronimo, C. M. P. et al. Methylprednisolone as adjunctive therapy for patients hospitalized with COVID-19 (Metcovid): A randomised, double-blind, phase IIb, placebo-controlled trial. Clin. Infect. Dis. (2020)."},{"key":"4778_CR21","unstructured":"World Health Organization. Corticosteroids for covid-19: Living guidance. 2 Sep 2020. https:\/\/www.who.int\/publications\/i\/item\/WHO-2019-nCoV-Corticosteroids-2020.1. (2020)."},{"key":"4778_CR22","unstructured":"National Institutes of Health (NIH). COVID-19 treatment guidelines https:\/\/www.covid19treatmentguidelines.nih.gov\/immune-based-therapy\/immunomodulators\/corticosteroids\/. (2020)."},{"key":"4778_CR23","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1007\/s40520-020-01570-8","volume":"32","author":"PC Ilie","year":"2020","unstructured":"Ilie, P. C., Stefanescu, S. & Smith, L. The role of vitamin D in the prevention of coronavirus disease 2019 infection and mortality. Aging Clin. Exp. Res. 32, 1195\u20131198 (2020).","journal-title":"Aging Clin. Exp. Res."},{"key":"4778_CR24","doi-asserted-by":"crossref","first-page":"988","DOI":"10.3390\/nu12040988","volume":"12","author":"WB Grant","year":"2020","unstructured":"Grant, W. B. et al. Evidence that vitamin D supplementation could reduce risk of influenza and COVID-19 infections and deaths. Nutrients 12, 988 (2020).","journal-title":"Nutrients"},{"key":"4778_CR25","doi-asserted-by":"crossref","first-page":"3361","DOI":"10.3390\/nu12113361","volume":"12","author":"J Mercola","year":"2020","unstructured":"Mercola, J., Grant, W. B. & Wagner, C. L. Evidence regarding vitamin D and risk of COVID-19 and its severity. Nutrients 12, 3361 (2020).","journal-title":"Nutrients"},{"key":"4778_CR26","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1529\/biophysj.103.035527","volume":"87","author":"I Oren","year":"2004","unstructured":"Oren, I., Fleishman, S. J., Kessel, A. & Ben-Tal, N. Free diffusion of steroid hormones across biomembranes: a simplex search with implicit solvent model calculations. Biophys. J. 87, 768\u2013779 (2004).","journal-title":"Biophys. J."},{"key":"4778_CR27","volume-title":"The Cell: A Molecular Approach","author":"GM Cooper","year":"2018","unstructured":"Cooper, G. M. & Hausman, R. E. The Cell: A Molecular Approach (Oxford University Press, Oxford, 2018)."},{"key":"4778_CR28","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1007\/s10867-018-9505-8","volume":"44","author":"AJ da Silva","year":"2018","unstructured":"da Silva, A. J. & Dos Santos, E. S. Aqueous solution interactions with sex hormone-binding globulin and estradiol: A theoretical investigation. J. Biol. Phys. 44, 539\u2013556 (2018).","journal-title":"J. Biol. Phys."},{"key":"4778_CR29","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.jinf.2020.03.046","volume":"81","author":"J Luan","year":"2020","unstructured":"Luan, J., Lu, Y., Gao, S. & Zhang, L. A potential inhibitory role for integrin in the receptor targeting of SARS-CoV-2. J. Infect. 81, 318\u2013356 (2020).","journal-title":"J. Infect."},{"key":"4778_CR30","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1016\/j.cell.2020.03.045","volume":"181","author":"Q Wang","year":"2020","unstructured":"Wang, Q. et al. Structural and functional basis of SARS-CoV-2 entry by using human ACE2. Cell 181, 894-904.e899 (2020).","journal-title":"Cell"},{"key":"4778_CR31","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/s41586-020-2180-5","volume":"581","author":"J Lan","year":"2020","unstructured":"Lan, J. et al. Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor. Nature 581, 215\u2013220 (2020).","journal-title":"Nature"},{"key":"4778_CR32","doi-asserted-by":"crossref","first-page":"154252","DOI":"10.1016\/j.metabol.2020.154252","volume":"108","author":"P Pozzilli","year":"2020","unstructured":"Pozzilli, P. & Lenzi, A. Commentary: Testosterone, a key hormone in the context of COVID-19 pandemic. Metabol. Clin. Exp. 108, 154252 (2020).","journal-title":"Metabol. Clin. Exp."},{"key":"4778_CR33","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1016\/j.fertnstert.2020.04.025","volume":"113","author":"J Segars","year":"2020","unstructured":"Segars, J. et al. Prior and novel coronaviruses, coronavirus disease 2019 (COVID-19), and human reproduction: What is known?. Fertil. Steril. 113, 1140\u20131149 (2020).","journal-title":"Fertil. Steril."},{"key":"4778_CR34","doi-asserted-by":"crossref","first-page":"7174","DOI":"10.1002\/ange.202015639","volume":"133","author":"DK Shoemark","year":"2021","unstructured":"Shoemark, D. K. et al. Molecular simulations suggest vitamins, retinoids and steroids as ligands of the free fatty acid pocket of the SARS-CoV-2 spike protein. Angew. Chem. 133, 7174\u20137186 (2021).","journal-title":"Angew. Chem."},{"key":"4778_CR35","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1126\/science.abd3255","volume":"370","author":"C Toelzer","year":"2020","unstructured":"Toelzer, C. et al. Free fatty acid binding pocket in the locked structure of SARS-CoV-2 spike protein. Science 370, 725\u2013730 (2020).","journal-title":"Science"},{"key":"4778_CR36","first-page":"1","volume":"39","author":"AD Elmezayen","year":"2020","unstructured":"Elmezayen, A. D., Al-Obaidi, A., \u015eahin, A. T. & Yelek\u00e7i, K. Drug repurposing for coronavirus (COVID-19): In silico screening of known drugs against coronavirus 3CL hydrolase and protease enzymes. J. Biomol. Struct. Dyn. 39, 1\u201313 (2020).","journal-title":"J. Biomol. Struct. Dyn."},{"key":"4778_CR37","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/s41586-020-2223-y","volume":"582","author":"Z Jin","year":"2020","unstructured":"Jin, Z. et al. Structure of M(pro) from SARS-CoV-2 and discovery of its inhibitors. Nature 582, 289\u2013293 (2020).","journal-title":"Nature"},{"key":"4778_CR38","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1038\/s41594-020-0440-6","volume":"27","author":"Z Jin","year":"2020","unstructured":"Jin, Z. et al. Structural basis for the inhibition of SARS-CoV-2 main protease by antineoplastic drug carmofur. Nat. Struct. Mol. Biol. 27, 529\u2013532 (2020).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"4778_CR39","first-page":"1","volume":"39","author":"SA Khan","year":"2020","unstructured":"Khan, S. A., Zia, K., Ashraf, S., Uddin, R. & Ul-Haq, Z. Identification of chymotrypsin-like protease inhibitors of SARS-CoV-2 via integrated computational approach. J. Biomol. Struct. Dyn. 39, 1\u201310 (2020).","journal-title":"J. Biomol. Struct. Dyn."},{"key":"4778_CR40","doi-asserted-by":"crossref","first-page":"14632","DOI":"10.1021\/bi061746y","volume":"45","author":"V Graziano","year":"2006","unstructured":"Graziano, V., McGrath, W. J., Yang, L. & Mangel, W. F. SARS CoV main proteinase: The monomer\u2212dimer equilibrium dissociation constant. Biochemistry 45, 14632\u201314641 (2006).","journal-title":"Biochemistry"},{"key":"4778_CR41","doi-asserted-by":"crossref","first-page":"107762","DOI":"10.1016\/j.jmgm.2020.107762","volume":"101","author":"M Bello","year":"2020","unstructured":"Bello, M. Prediction of potential inhibitors of the dimeric SARS-CoV2 main proteinase through the MM\/GBSA approach. J. Mol. Graph. Model 101, 107762 (2020).","journal-title":"J. Mol. Graph. Model"},{"key":"4778_CR42","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1126\/science.abf7945","volume":"372","author":"S G\u00fcnther","year":"2021","unstructured":"G\u00fcnther, S. et al. X-ray screening identifies active site and allosteric inhibitors of SARS-CoV-2 main protease. Science 372, 642\u2013646 (2021).","journal-title":"Science"},{"key":"4778_CR43","unstructured":"Guenther, S. et al. Inhibition of SARS-CoV-2 main protease by allosteric drug-binding. bioRxiv (2020)."},{"key":"4778_CR44","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.jmgm.2017.02.016","volume":"74","author":"A Mansouri","year":"2017","unstructured":"Mansouri, A. & Mahnam, K. Designing new surfactant peptides for binding to carbon nanotubes via computational approaches. J. Mol. Graph. Model. 74, 61\u201372 (2017).","journal-title":"J. Mol. Graph. Model."},{"key":"4778_CR45","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.jmgm.2016.01.003","volume":"64","author":"A Barzegar","year":"2016","unstructured":"Barzegar, A., Mansouri, A. & Azamat, J. Molecular dynamics simulation of non-covalent single-walled carbon nanotube functionalization with surfactant peptides. J. Mol. Graph. Model. 64, 75\u201384 (2016).","journal-title":"J. Mol. Graph. Model."},{"key":"4778_CR46","doi-asserted-by":"crossref","first-page":"16944","DOI":"10.1039\/C8DT03079K","volume":"47","author":"M Hosseini-Kharat","year":"2018","unstructured":"Hosseini-Kharat, M. et al. In vitro and in vivo antiproliferative activity of organo-nickel SCS-pincer complexes on estrogen responsive MCF7 and MC4L2 breast cancer cells. Effects of amine fragment substitutions on BSA binding and cytotoxicity. Dalton Trans. 47, 16944\u201316957 (2018).","journal-title":"Dalton Trans."},{"key":"4778_CR47","doi-asserted-by":"crossref","first-page":"17193","DOI":"10.3390\/ijms160817193","volume":"16","author":"JF D\u00edaz-Villanueva","year":"2015","unstructured":"D\u00edaz-Villanueva, J. F., D\u00edaz-Molina, R. & Garc\u00eda-Gonz\u00e1lez, V. Protein folding and mechanisms of proteostasis. Int. J. Mol. Sci. 16, 17193\u201317230 (2015).","journal-title":"Int. J. Mol. Sci."},{"key":"4778_CR48","doi-asserted-by":"crossref","first-page":"108427","DOI":"10.1016\/j.clim.2020.108427","volume":"215","author":"K Yuki","year":"2020","unstructured":"Yuki, K., Fujiogi, M. & Koutsogiannaki, S. COVID-19 pathophysiology: A review. Clin Immunol 215, 108427 (2020).","journal-title":"Clin Immunol"},{"key":"4778_CR49","doi-asserted-by":"crossref","first-page":"3189","DOI":"10.1038\/s41598-019-39081-w","volume":"9","author":"R Kowsar","year":"2019","unstructured":"Kowsar, R., Keshtegar, B. & Miyamoto, A. Understanding the hidden relations between pro- and anti-inflammatory cytokine genes in bovine oviduct epithelium using a multilayer response surface method. Sci. Rep. 9, 3189 (2019).","journal-title":"Sci. Rep."},{"key":"4778_CR50","doi-asserted-by":"crossref","unstructured":"Asadi, L., Tabatabaei, R. S., Safinejad, H. & Mohammadi, M. New corona virus (COVID-19) management in pregnancy and childbirth. Arch. Clin. Infect. Dis. 15 (2020).","DOI":"10.5812\/archcid.102938"},{"key":"4778_CR51","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1002\/jcc.21334","volume":"31","author":"O Trott","year":"2010","unstructured":"Trott, O. & Olson, A. J. AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J. Comput. Chem. 31, 455\u2013461. https:\/\/doi.org\/10.1002\/jcc.21334 (2010).","journal-title":"J. Comput. Chem."},{"key":"4778_CR52","doi-asserted-by":"crossref","first-page":"633","DOI":"10.2174\/1389557516666160609080157","volume":"17","author":"A Barzegar","year":"2017","unstructured":"Barzegar, A., Naghizadeh, E., Zakariazadeh, M. & Azamat, J. Molecular dynamics simulation study of the HIV-1 protease inhibit ion using fullerene and new fullerene derivatives of carbon nanostructures. Mini Rev. Med. Chem. 17, 633\u2013647 (2017).","journal-title":"Mini Rev. Med. Chem."},{"key":"4778_CR53","doi-asserted-by":"crossref","first-page":"e1004586","DOI":"10.1371\/journal.pcbi.1004586","volume":"11","author":"PA Ravindranath","year":"2015","unstructured":"Ravindranath, P. A., Forli, S., Goodsell, D. S., Olson, A. J. & Sanner, M. F. AutoDockFR: Advances in protein-ligand docking with explicitly specified binding site flexibility. PLoS Comput. Biol. 11, e1004586 (2015).","journal-title":"PLoS Comput. Biol."},{"key":"4778_CR54","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1021\/acscentsci.1c00039","volume":"7","author":"C-H Zhang","year":"2021","unstructured":"Zhang, C.-H. et al. Potent noncovalent inhibitors of the main protease of SARS-CoV-2 from molecular sculpting of the drug perampanel guided by free energy perturbation calculations. ACS Cent. Sci 7, 467\u2013475 (2021).","journal-title":"ACS Cent. Sci"},{"key":"4778_CR55","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.jmb.2015.09.014","volume":"428","author":"GCP van Zundert","year":"2016","unstructured":"van Zundert, G. C. P. et al. The HADDOCK2.2 web server: User-friendly integrative modeling of biomolecular complexes. J. Mol. Biol. 428, 720\u2013725 (2016).","journal-title":"J. Mol. Biol."},{"key":"4778_CR56","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1021\/ci500020m","volume":"54","author":"R Kumari","year":"2014","unstructured":"Kumari, R., Kumar, R. & Lynn, A. g_mmpbsa\u2014A GROMACS tool for high-throughput MM-PBSA calculations. J. Chem. Inf. Model. 54, 1951\u20131962 (2014).","journal-title":"J. Chem. Inf. Model."},{"key":"4778_CR57","doi-asserted-by":"crossref","first-page":"10037","DOI":"10.1073\/pnas.181342398","volume":"98","author":"NA Baker","year":"2001","unstructured":"Baker, N. A., Sept, D., Joseph, S., Holst, M. J. & McCammon, J. A. Electrostatics of nanosystems: Application to microtubules and the ribosome. Proc. Natl. Acad. Sci. 98, 10037\u201310041 (2001).","journal-title":"Proc. Natl. Acad. Sci."},{"key":"4778_CR58","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1021\/ct700200b","volume":"4","author":"B Hess","year":"2008","unstructured":"Hess, B. P-LINCS: A parallel linear constraint solver for molecular simulation. J. Chem. Theory Comput. 4, 116\u2013122 (2008).","journal-title":"J. Chem. Theory Comput."},{"key":"4778_CR59","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.softx.2015.06.001","volume":"1","author":"MJ Abraham","year":"2015","unstructured":"Abraham, M. J. et al. GROMACS: High performance molecular simulations through multi-level parallelism from laptops to supercomputers. SoftwareX 1, 19\u201325 (2015).","journal-title":"SoftwareX"},{"key":"4778_CR60","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1021\/ct900549r","volume":"6","author":"P Bjelkmar","year":"2010","unstructured":"Bjelkmar, P., Larsson, P., Cuendet, M. A., Hess, B. & Lindahl, E. Implementation of the CHARMM Force Field in GROMACS: Analysis of protein stability effects from correction maps, virtual interaction sites, and water models. J. Chem. Theory Comput. 6, 459\u2013466 (2010).","journal-title":"J. Chem. Theory Comput."},{"key":"4778_CR61","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1002\/jcc.21816","volume":"32","author":"V Zoete","year":"2011","unstructured":"Zoete, V., Cuendet, M. A., Grosdidier, A. & Michielin, O. SwissParam: A fast force field generation tool for small organic molecules. J. Comput. Chem. 32, 2359\u20132368 (2011).","journal-title":"J. Comput. Chem."},{"key":"4778_CR62","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1002\/jcc.21287","volume":"30","author":"BR Brooks","year":"2009","unstructured":"Brooks, B. R. et al. CHARMM: The biomolecular simulation program. J. Comput. Chem. 30, 1545\u20131614 (2009).","journal-title":"J. Comput. Chem."},{"key":"4778_CR63","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1021\/acs.jctc.5b00935","volume":"12","author":"J Lee","year":"2016","unstructured":"Lee, J. et al. CHARMM-GUI input generator for NAMD, GROMACS, AMBER, OpenMM, and CHARMM\/OpenMM simulations using the CHARMM36 additive force field. J. Chem. Theory Comput. 12, 405\u2013413 (2016).","journal-title":"J. Chem. Theory Comput."},{"key":"4778_CR64","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1093\/bioinformatics\/bts310","volume":"28","author":"A Volkamer","year":"2012","unstructured":"Volkamer, A., Kuhn, D., Rippmann, F. & Rarey, M. DoGSiteScorer: A web server for automatic binding site prediction, analysis and druggability assessment. Bioinformatics 28, 2074\u20132075 (2012).","journal-title":"Bioinformatics"},{"key":"4778_CR65","doi-asserted-by":"crossref","first-page":"W337","DOI":"10.1093\/nar\/gkx333","volume":"45","author":"R F\u00e4hrrolfes","year":"2017","unstructured":"F\u00e4hrrolfes, R. et al. ProteinsPlus: A web portal for structure analysis of macromolecules. Nucleic Acids Res. 45, W337-w343 (2017).","journal-title":"Nucleic Acids Res."},{"key":"4778_CR66","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1038\/nrd892","volume":"1","author":"AL Hopkins","year":"2002","unstructured":"Hopkins, A. L. & Groom, C. R. The druggable genome. Nat. Rev. Drug Discov. 1, 727\u2013730 (2002).","journal-title":"Nat. Rev. Drug Discov."},{"key":"4778_CR67","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1021\/ci800324m","volume":"49","author":"TA Halgren","year":"2009","unstructured":"Halgren, T. A. Identifying and characterizing binding sites and assessing druggability. J. Chem. Inf. Model. 49, 377\u2013389 (2009).","journal-title":"J. Chem. Inf. Model."},{"key":"4778_CR68","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.drudis.2010.05.015","volume":"15","author":"S P\u00e9rot","year":"2010","unstructured":"P\u00e9rot, S., Sperandio, O., Miteva, M. A., Camproux, A. C. & Villoutreix, B. O. Druggable pockets and binding site centric chemical space: A paradigm shift in drug discovery. Drug Discov. Today 15, 656\u2013667 (2010).","journal-title":"Drug Discov. Today"},{"key":"4778_CR69","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1002\/prot.340230412","volume":"23","author":"D Frishman","year":"1995","unstructured":"Frishman, D. & Argos, P. Knowledge-based protein secondary structure assignment. Proteins 23, 566\u2013579 (1995).","journal-title":"Proteins"},{"key":"4778_CR70","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1021\/ci025515j","volume":"42","author":"IV Tetko","year":"2002","unstructured":"Tetko, I. V. & Tanchuk, V. Y. Application of associative neural networks for prediction of lipophilicity in ALOGPS 2.1 program. J. Chem. Inform. Comput. Sci. 42, 1136\u20131145 (2002).","journal-title":"J. Chem. Inform. Comput. Sci."},{"key":"4778_CR71","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1093\/protein\/8.2.127","volume":"8","author":"AC Wallace","year":"1995","unstructured":"Wallace, A. C., Laskowski, R. A. & Thornton, J. M. LIGPLOT: A program to generate schematic diagrams of protein-ligand interactions. Protein Eng. 8, 127\u2013134 (1995).","journal-title":"Protein Eng."},{"key":"4778_CR72","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1038\/s41577-020-0348-8","volume":"20","author":"EP Scully","year":"2020","unstructured":"Scully, E. P., Haverfield, J., Ursin, R. L., Tannenbaum, C. & Klein, S. L. Considering how biological sex impacts immune responses and COVID-19 outcomes. Nat. Rev. Immunol. 20, 442\u2013447 (2020).","journal-title":"Nat. Rev. Immunol."},{"key":"4778_CR73","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1038\/nri.2016.90","volume":"16","author":"SL Klein","year":"2016","unstructured":"Klein, S. L. & Flanagan, K. L. Sex differences in immune responses. Nat. Rev. Immunol. 16, 626\u2013638 (2016).","journal-title":"Nat. Rev. Immunol."},{"key":"4778_CR74","first-page":"102116","volume":"50","author":"AJ Li","year":"2020","unstructured":"Li, A. J. & Li, X. Sex-dependent immune response and lethality of COVID-19. Stem Cell Res. 50, 102116 (2020).","journal-title":"Stem Cell Res."},{"key":"4778_CR75","doi-asserted-by":"crossref","unstructured":"Aguilar-Pineda, J. A. et al. Structural and functional analysis of female sex hormones against SARS-Cov2 cell entry. bioRxiv (2020).","DOI":"10.1101\/2020.07.29.227249"},{"key":"4778_CR76","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/S0140-6736(20)30317-2","volume":"395","author":"CD Russell","year":"2020","unstructured":"Russell, C. D., Millar, J. E. & Baillie, J. K. Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury. Lancet 395, 473\u2013475 (2020).","journal-title":"Lancet"},{"key":"4778_CR77","doi-asserted-by":"crossref","first-page":"2866","DOI":"10.1002\/jmv.26165","volume":"92","author":"L Kolilekas","year":"2020","unstructured":"Kolilekas, L. et al. Can steroids reverse the severe COVID-19 induced \u201ccytokine storm\u201d?. J. Med. Virol. 92, 2866\u20132869 (2020).","journal-title":"J. Med. Virol."},{"key":"4778_CR78","doi-asserted-by":"crossref","first-page":"e00596","DOI":"10.1002\/rcr2.596","volume":"8","author":"C So","year":"2020","unstructured":"So, C., Ro, S., Murakami, M., Imai, R. & Jinta, T. High-dose, short-term corticosteroids for ARDS caused by COVID-19: A case series. Respirol. Case Rep. 8, e00596 (2020).","journal-title":"Respirol. Case Rep."},{"key":"4778_CR79","unstructured":"The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China. Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi 41, 145\u2013151 (2020)."},{"key":"4778_CR80","first-page":"1","volume":"10","author":"S Zhao","year":"2020","unstructured":"Zhao, S. et al. The time-varying serial interval of the coronavirus disease (COVID-19) and its gender-specific difference: A data-driven analysis using public surveillance data in Hong Kong and Shenzhen, China from January 10 to February 15, 2020. Infect. Control Hosp. Epidemiol. 10, 1\u20138 (2020).","journal-title":"Infect. Control Hosp. Epidemiol."},{"key":"4778_CR81","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1111\/liv.13303","volume":"37","author":"A Magri","year":"2017","unstructured":"Magri, A. et al. 17, \u03b2-estradiol inhibits hepatitis C virus mainly by interference with the release phase of its life cycle. Liver Int. 37, 669\u2013677 (2017).","journal-title":"Liver Int."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-04778-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-04778-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-04778-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,15]],"date-time":"2023-11-15T20:17:02Z","timestamp":1700079422000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-04778-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,13]]},"references-count":81,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["4778"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-04778-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,13]]},"assertion":[{"value":"6 July 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 December 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 January 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"717"}}